Ismail Hdoufane

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 10

Top Topics

Molecular Docking

Iron Deficiency

Hepatitis C Virus

Top Venues

Pharmaceuticals (Basel, Switzerland)

Journal of biomolecular structure & dynamics

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Mohamed Adardour, Marouane Ait Lahcen, Mehdi Oubahmane, Walid Ettahiri, Ismail Hdoufane, Hafida Bouamama, A F M Motiur Rahman, Driss Cherqaoui, Mustapha Taleb, Elena Zaballos Garcia, Abdesselam Baouid
Design, Synthesis, Molecular Modeling and Biological Evaluation of Novel Pyrazole Benzimidazolone Derivatives as Potent Antioxidants. Pharmaceuticals (Basel, Switzerland) 16 (12) (2023)
Mohamed Adardour, Marouane Ait Lahcen, Mehdi Oubahmane, Walid Ettahiri, Ismail Hdoufane, Hafida Bouamama, A F M Motiur Rahman, Driss Cherqaoui, Mustapha Taleb, Elena Zaballos Garcia, Abdesselam Baouid
Design, Synthesis, Molecular Modeling and Biological Evaluation of Novel Pyrazole Benzimidazolone Derivatives as Potent Antioxidants. Pharmaceuticals (Basel, Switzerland) 16 (12) (2023)
Mehdi Oubahmane, Ismail Hdoufane, Christelle Delaite, Adlane Sayede, Driss Cherqaoui, Achraf El Allali
Design of Potent Inhibitors Targeting the Main Protease of SARS-CoV-2 Using QSAR Modeling, Molecular Docking, and Molecular Dynamics Simulations. Pharmaceuticals (Basel, Switzerland) 16 (4) (2023)
Mehdi Oubahmane, Ismail Hdoufane, Christelle Delaite, Adlane Sayede, Driss Cherqaoui, Achraf El Allali
Design of Potent Inhibitors Targeting the Main Protease of SARS-CoV-2 Using QSAR Modeling, Molecular Docking, and Molecular Dynamics Simulations. Pharmaceuticals (Basel, Switzerland) 16 (4) (2023)
Mehdi Oubahmane, Ismail Hdoufane, Christelle Delaite, Adlane Sayede, Driss Cherqaoui, Achraf El Allali
Design of Potent Inhibitors Targeting the Main Protease of SARS-CoV-2 Using QSAR Modeling, Molecular Docking, and Molecular Dynamics Simulations. Pharmaceuticals (Basel, Switzerland) 16 (4) (2023)
Wissal Liman, Nouhaila Ait Lahcen, Mehdi Oubahmane, Ismail Hdoufane, Driss Cherqaoui, Rachid Daoud, Achraf El Allali
Hybrid Molecules as Potential Drugs for the Treatment of HIV: Design and Applications. Pharmaceuticals (Basel, Switzerland) 15 (9) (2022)
Wissal Liman, Mehdi Oubahmane, Ismail Hdoufane, Imane Bjij, Didier Villemin, Rachid Daoud, Driss Cherqaoui, Achraf El Allali
Monte Carlo Method and GA-MLR-Based QSAR Modeling of NS5A Inhibitors against the Hepatitis C Virus. Molecules (Basel, Switzerland) 27 (9) (2022)
Zahira Tber, Mohammed Loubidi, Jabrane Jouha, Ismail Hdoufane, Mümin Alper Erdogan, Sarmistha Saha, Güliz Armagan, Sabine Berteina-Raboin
Pyrido[2',1':2,3]imidazo[4,5-c]isoquinolin-5-amines as Potential Cytotoxic Agents against Human Neuroblastoma. Pharmaceuticals (Basel, Switzerland) 14 (8) (2021)
Ismail Hdoufane, Imane Bjij, Mehdi Oubahmane, Mahmoud E S Soliman, Didier Villemin, Driss Cherqaoui
In silico design and analysis of NS4B inhibitors against hepatitis C virus. Journal of biomolecular structure & dynamics (2020)
Ismail Hdoufane, Imane Bjij, Mahmoud Soliman, Alia Tadjer, Didier Villemin, Jane Bogdanov, Driss Cherqaoui
In Silico SAR Studies of HIV-1 Inhibitors. Pharmaceuticals (Basel, Switzerland) 11 (3) (2018)